Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 13 studies | 42% ± 13% | |
oligodendrocyte precursor cell | 13 studies | 65% ± 21% | |
GABAergic neuron | 9 studies | 43% ± 18% | |
glutamatergic neuron | 6 studies | 43% ± 13% | |
interneuron | 5 studies | 46% ± 20% | |
amacrine cell | 3 studies | 49% ± 17% | |
GABAergic amacrine cell | 3 studies | 68% ± 11% | |
glycinergic amacrine cell | 3 studies | 33% ± 14% | |
neuron | 3 studies | 53% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 34% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 1235.16 | 2606 / 2642 | 95% | 82.61 | 672 / 705 |
liver | 82% | 211.82 | 186 / 226 | 83% | 14.25 | 337 / 406 |
kidney | 93% | 658.91 | 83 / 89 | 17% | 1.92 | 151 / 901 |
lung | 17% | 30.77 | 100 / 578 | 47% | 4.51 | 540 / 1155 |
prostate | 0% | 0 | 0 / 245 | 31% | 2.36 | 156 / 502 |
esophagus | 1% | 1.23 | 11 / 1445 | 21% | 1.43 | 38 / 183 |
breast | 12% | 21.23 | 56 / 459 | 6% | 0.26 | 63 / 1118 |
intestine | 3% | 5.53 | 33 / 966 | 13% | 0.67 | 71 / 527 |
bladder | 0% | 0 | 0 / 21 | 16% | 0.96 | 80 / 504 |
pancreas | 0% | 0 | 0 / 328 | 10% | 2.70 | 17 / 178 |
stomach | 0% | 0.47 | 1 / 359 | 9% | 0.63 | 26 / 286 |
skin | 0% | 0.12 | 2 / 1809 | 8% | 0.80 | 40 / 472 |
uterus | 0% | 0 | 0 / 170 | 7% | 0.43 | 32 / 459 |
adrenal gland | 1% | 4.66 | 2 / 258 | 6% | 2.93 | 13 / 230 |
ovary | 0% | 0 | 0 / 180 | 6% | 0.28 | 25 / 430 |
thymus | 0% | 0 | 0 / 653 | 5% | 0.18 | 29 / 605 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.08 | 1 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.07 | 1 / 45 |
eye | 0% | 0 | 0 / 0 | 1% | 0.05 | 1 / 80 |
peripheral blood | 0% | 3.17 | 2 / 929 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.14 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0007399 | Biological process | nervous system development |
GO_0046839 | Biological process | phospholipid dephosphorylation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0043005 | Cellular component | neuron projection |
GO_0008195 | Molecular function | phosphatidate phosphatase activity |
GO_0052642 | Molecular function | lysophosphatidic acid phosphatase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PLPPR1 |
Protein name | Phospholipid phosphatase-related protein type 1 (Inactive 2-lysophosphatidate phosphatase PLPPR1) (Lipid phosphate phosphatase-related protein type 1) (Plasticity-related gene 3 protein) (PRG-3) Phospholipid phosphatase-related protein type 1 (Inactive 2-lysophosphatidate phosphatase PLPPR1) (Lipid phosphate phosphatase-related protein type 1) Phospholipid phosphatase related 1 (Phospholipid phosphatase-related protein type 1) |
Synonyms | LPPR1 PRG3 |
Description | FUNCTION: May play a role in neurite outgrowth and neurogenesis. . FUNCTION: May play a role in neurite outgrowth and neurogenesis. . |
Accessions | ENST00000611695.4 Q8TBJ4 ENST00000456287.5 A0A0J9YYG5 ENST00000632580.1 ENST00000633861.1 ENST00000374874.8 ENST00000395056.2 M9MML5 ENST00000614834.2 |